Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars' Pediatric Pressures Could Push Them Toward Interchangeability

Jul 15 2016

• By Derrick Gingery

ChildInjection_1200x675

Related Content

Pediatric Study Waiver, Deferral Determinations Could Harm Approvals, Firms Tell FDA

Sep 30 2013

Biosimilar Advisory Committee Features Actual Debate About Biosimilarity

Jul 14 2016

Sandoz Steers Enbrel Biosimilar Away From Equivalence Quandary With Reanalysis

Jul 11 2016

<em>Zarxio</em> Syringe’s Limitations May Delay Decision On <em>Neupogen</em> Interchangeability

Jun 15 2015

Biosimilar Sponsors May Seek Interchangeability Before FDA Sets Rules

Apr 24 2015

Biosimilar Non-Medical Switching: Advocacy Groups, FDA Advisors Push For Action

Jul 15 2016

Related Companies

Novartis AG

Amgen, Inc.

Additional Topics

United States Regulation Policy Biosimilars Advisory Committees Drug Review Inflammation

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window